Higher Susceptibility of Cerebral Cortex and Striatum to Sulfite Neurotoxicity
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Human Sulfite Oxidase R160Q: Identification of the Mutation in a Sulfite Oxidase-Deficient Patient and Expression and Characterization of the Mutant Enzyme
Proc. Natl. Acad. Sci. USA Vol. 95, pp. 6394–6398, May 1998 Medical Sciences Human sulfite oxidase R160Q: Identification of the mutation in a sulfite oxidase-deficient patient and expression and characterization of the mutant enzyme ROBERT M. GARRETT*†,JEAN L. JOHNSON*, TYLER N. GRAF*, ANNETTE FEIGENBAUM‡, AND K. V. RAJAGOPALAN*§ *Department of Biochemistry, Duke University Medical Center, Durham, NC 27710; and ‡Department of Genetics, The Hospital for Sick Children and University of Toronto, 555 University Avenue, Toronto, ON, Canada M5G 1X8 Edited by Irwin Fridovich, Duke University Medical Center, Durham, NC, and approved March 19, 1998 (received for review February 17, 1998) ABSTRACT Sulfite oxidase catalyzes the terminal reac- tion in the degradation of sulfur amino acids. Genetic defi- ciency of sulfite oxidase results in neurological abnormalities and often leads to death at an early age. The mutation in the sulfite oxidase gene responsible for sulfite oxidase deficiency in a 5-year-old girl was identified by sequence analysis of cDNA obtained from fibroblast mRNA to be a guanine to adenine transition at nucleotide 479 resulting in the amino acid substitution of Arg-160 to Gln. Recombinant protein containing the R160Q mutation was expressed in Escherichia coli, purified, and characterized. The mutant protein con- tained its full complement of molybdenum and heme, but exhibited 2% of native activity under standard assay condi- tions. Absorption spectroscopy of the isolated molybdenum domains of native sulfite oxidase and of the R160Q mutant showed significant differences in the 480- and 350-nm absorp- tion bands, suggestive of altered geometry at the molybdenum center. -
Glutathione Reductase (Ec 1.6.4.2)
Enzymatic Assay of GLUTATHIONE REDUCTASE (EC 1.6.4.2) PRINCIPLE: ß-NADPH + GSSG Glutathione Reductase> ß-NADP + 2 GSH Abbreviations used: ß-NADPH = ß-Nicotinamide Adenine Dinucleotide Phosphate, Reduced Form ß-NADP = ß-Nicotinamide Adenine Dinucleotide Phosphate, Oxidized Form GSSG = Glutathione, Oxidized Form GSH = Glutathione, Reduced Form CONDITIONS: T = 25°C, pH = 7.6, A340nm, Light Path = 1 cm METHOD: Continuous Spectrophotometric Rate Determination REAGENTS: A. 100 mM Potassium Phosphate Buffer with 3.4 mM Ethylenediaminetetraacetic Acid (EDTA), pH 7.6 at 25°C (Prepare 200 ml in deionized water using Potassium Phosphate, Monobasic, Anhydrous, Sigma Prod. No. P-5379 and Ethylenediaminetetraacetic Acid, Dipotassium Salt, Sigma Stock No. ED2P. Adjust to pH 7.6 at 25°C with 1 M KOH.) B. 30 mM Glutathione Substrate Solution (GSSG) (Prepare 5 ml in deionized water using Glutathione, Oxidized Form, Disodium Salt, Sigma Prod. No. G-4626.) C. 0.8 mM ß-Nicotinamide Adenine Dinucleotide Phosphate, Reduced Form Solution (ß-NADPH) (Prepare 5 ml in cold Reagent A using ß-Nicotinamide Adenine Dinucleotide Phosphate, Tetrasodium Salt, Sigma Prod. No. N-1630.) D. 1.0% (w/v) Bovine Serum Albumin (BSA) (Prepare 100 ml in Reagent A using Albumin, Bovine, Sigma Prod. No. A-4503. This solution should be kept cold.) SPGLUT01 Page 1 of 3 Revised: 08/03/95 Enzymatic Assay of GLUTATHIONE REDUCTASE (EC 1.6.4.2) REAGENTS: (continued) E. Glutathione Reductase Enzyme Solution (Immediately before use, prepare a solution containing 0.30 - 0.60 unit/ml of Glutathione Reductase in cold Reagent D.) PROCEDURE: Pipette (in milliliters) the following reagents into suitable cuvettes: Test Blank Deionized Water 0.65 0.65 Reagent A (Buffer) 1.50 1.50 Reagent B (GSSG) 0.10 0.10 Reagent C (ß-NADPH) 0.35 0.35 Reagent D (BSA) 0.30 0.40 Mix by inversion and equilibrate to 25°C. -
Glutathione Reductase Human, Recombinant Expressed in Escherichia Coli
Glutathione Reductase human, recombinant expressed in Escherichia coli Catalog Number G9297 Storage Temperature –20 °C CAS RN 9001-48-3 Precautions and Disclaimer EC 1.8.1.7 (formerly 1.6.4.2) This product is for R&D use only, not for drug, Synonyms: GR, NADPH:oxidized glutathione household, or other uses. Please consult the Material oxidoreductase, glutathione-disulfide reductase Safety Data Sheet for information regarding hazards and safe handling practices. Product Description Glutathione reductase (GR) is an ubiquitous Storage/Stability flavoenzyme involved in protecting cells from stress. The product ships on wet ice and storage at –20 °C is GR catalyzes the reduction of oxidized glutathione recommended. The product is stable at –20 °C for at (GSSG) to glutathione (GSH). It is an essential least 2 years. component of the glutathione redox cycle, which maintains adequate levels of reduced cellular GSH. References GSH serves as an antioxidant, reacting with free 1. Lopez-Mirabal, H.R., and Winther, J.R., Redox radicals and organic peroxides. Glutathione is also an characteristics of the eukaryotic cytosol. Biochim. electron donor for glutathione peroxidases and a Biophys. Acta, 1783, 629-640 (2008). substrate for glutathione S-transferases contributing to 2. Qiao, M., et al., Increased expression of glutathione the detoxification and elimination of toxic electrophilic reductase in macrophages decreases 1,2 metabolites and xenobiotics. artherosclerotic lesion formation on low-density lipoproetin receptor-deficient mice. Arterioscler. Glutathione reductase is a homodimeric enzyme Thromb. Vasc. Biol., 27, 1375-1382 (2007). containing 1 FAD molecule and 1 NADPH binding 3. Worthington, D.J., and Rosemeyer, M.A., 3 domain per subunit. -
Amino Acid Disorders
471 Review Article on Inborn Errors of Metabolism Page 1 of 10 Amino acid disorders Ermal Aliu1, Shibani Kanungo2, Georgianne L. Arnold1 1Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 2Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA Contributions: (I) Conception and design: S Kanungo, GL Arnold; (II) Administrative support: S Kanungo; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: E Aliu, GL Arnold; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Georgianne L. Arnold, MD. UPMC Children’s Hospital of Pittsburgh, 4401 Penn Avenue, Suite 1200, Pittsburgh, PA 15224, USA. Email: [email protected]. Abstract: Amino acids serve as key building blocks and as an energy source for cell repair, survival, regeneration and growth. Each amino acid has an amino group, a carboxylic acid, and a unique carbon structure. Human utilize 21 different amino acids; most of these can be synthesized endogenously, but 9 are “essential” in that they must be ingested in the diet. In addition to their role as building blocks of protein, amino acids are key energy source (ketogenic, glucogenic or both), are building blocks of Kreb’s (aka TCA) cycle intermediates and other metabolites, and recycled as needed. A metabolic defect in the metabolism of tyrosine (homogentisic acid oxidase deficiency) historically defined Archibald Garrod as key architect in linking biochemistry, genetics and medicine and creation of the term ‘Inborn Error of Metabolism’ (IEM). The key concept of a single gene defect leading to a single enzyme dysfunction, leading to “intoxication” with a precursor in the metabolic pathway was vital to linking genetics and metabolic disorders and developing screening and treatment approaches as described in other chapters in this issue. -
Molybdenum Cofactor and Sulfite Oxidase Deficiency Jochen Reiss* Institute of Human Genetics, University Medicine Göttingen, Germany
ics: O om pe ol n b A a c t c e e M s s Reiss, Metabolomics (Los Angel) 2016, 6:3 Metabolomics: Open Access DOI: 10.4172/2153-0769.1000184 ISSN: 2153-0769 Research Article Open Access Molybdenum Cofactor and Sulfite Oxidase Deficiency Jochen Reiss* Institute of Human Genetics, University Medicine Göttingen, Germany Abstract A universal molybdenum-containing cofactor is necessary for the activity of all eukaryotic molybdoenzymes. In humans four such enzymes are known: Sulfite oxidase, xanthine oxidoreductase, aldehyde oxidase and a mitochondrial amidoxime reducing component. Of these, sulfite oxidase is the most important and clinically relevant one. Mutations in the genes MOCS1, MOCS2 or GPHN - all encoding cofactor biosynthesis proteins - lead to molybdenum cofactor deficiency type A, B or C, respectively. All three types plus mutations in the SUOX gene responsible for isolated sulfite oxidase deficiency lead to progressive neurological disease which untreated in most cases leads to death in early childhood. Currently, only for type A of the cofactor deficiency an experimental treatment is available. Introduction combination with SUOX deficiency. Elevated xanthine and lowered uric acid concentrations in the urine are used to differentiate this Isolated sulfite oxidase deficiency (MIM#606887) is an autosomal combined form from the isolated SUOX deficiency. Rarely and only in recessive inherited disease caused by mutations in the sulfite oxidase cases of isolated XOR deficiency xanthine stones have been described (SUOX) gene [1]. Sulfite oxidase is localized in the mitochondrial as a cause of renal failure. Otherwise, isolated XOR deficiency often intermembrane space, where it catalyzes the oxidation of sulfite to goes unnoticed. -
Glutathione Reductase Assay Kit
Glutathione Reductase Assay Kit Item No. 703202 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd · Ann Arbor, MI · USA TABLE OF CONTENTS GENERAL INFORMATION GENERAL INFORMATION 3 Materials Supplied Materials Supplied 4 Safety Data 4 Precautions 5 If You Have Problems Item Number Item Quantity 4 Storage and Stability 703210 GR Assay Buffer (10X) 1 vial 4 Materials Needed but Not Supplied INTRODUCTION 5 Background 703212 GR Sample Buffer (10X) 1 vial 5 About This Assay 703214 GR Glutathione Reductase (control) 1 vial PRE-ASSAY PREPARATION 6 Reagent Preparation 7 Sample Preparation 703216 GR GSSG 1 vial ASSAY PROTOCOL 9 Plate Set Up 703218 GR NADPH 3 vials 11 Performing the Assay 400014 96-Well Solid Plate (Colorimetric Assay) 1 plate ANALYSIS 12 Calculations 13 Performance Characteristics 400012 96-Well Cover Sheet 1 cover RESOURCES 14 Interferences If any of the items listed above are damaged or missing, please contact our 16 Troubleshooting Customer Service department at (800) 364-9897 or (734) 971-3335. We cannot 17 References accept any returns without prior authorization. 18 Plate Template 19 Notes WARNING: THIS PRODUCT IS FOR RESEARCH ONLY - NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE. 19 Warranty and Limitation of Remedy ! GENERAL INFORMATION 3 Safety Data INTRODUCTION This material should be considered hazardous until further information becomes available. Do not ingest, inhale, get in eyes, on skin, or on clothing. Wash Background thoroughly after handling. Before use, the user must review the complete Safety Glutathione (GSH) is a tripeptide widely distributed in both plants and Data Sheet, which has been sent via email to your institution. -
Mechanistic Study of Cysteine Dioxygenase, a Non-Heme
MECHANISTIC STUDY OF CYSTEINE DIOXYGENASE, A NON-HEME MONONUCLEAR IRON ENZYME by WEI LI Presented to the Faculty of the Graduate School of The University of Texas at Arlington in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY THE UNIVERSITY OF TEXAS AT ARLINGTON August 2014 Copyright © by Student Name Wei Li All Rights Reserved Acknowledgements I would like to thank Dr. Pierce for your mentoring, guidance and patience over the five years. I cannot go all the way through this without your help. Your intelligence and determination has been and will always be an example for me. I would like to thank my committee members Dr. Dias, Dr. Heo and Dr. Jonhson- Winters for the directions and invaluable advice. I also would like to thank all my lab mates, Josh, Bishnu ,Andra, Priyanka, Eleanor, you all helped me so I could finish my projects. I would like to thank the Department of Chemistry and Biochemistry for the help with my academic and career. At Last, I would like to thank my lovely wife and beautiful daughter who made my life meaningful and full of joy. July 11, 2014 iii Abstract MECHANISTIC STUDY OF CYSTEINE DIOXYGENASE A NON-HEME MONONUCLEAR IRON ENZYME Wei Li, PhD The University of Texas at Arlington, 2014 Supervising Professor: Brad Pierce Cysteine dioxygenase (CDO) is an non-heme mononuclear iron enzymes that catalyzes the O2-dependent oxidation of L-cysteine (Cys) to produce cysteine sulfinic acid (CSA). CDO controls cysteine levels in cells and is a potential drug target for some diseases such as Parkinson’s and Alzhermer’s. -
Ferroptosis-Related Flavoproteins: Their Function and Stability
International Journal of Molecular Sciences Review Ferroptosis-Related Flavoproteins: Their Function and Stability R. Martin Vabulas Charité-Universitätsmedizin, Institute of Biochemistry, Charitéplatz 1, 10117 Berlin, Germany; [email protected]; Tel.: +49-30-4505-28176 Abstract: Ferroptosis has been described recently as an iron-dependent cell death driven by peroxida- tion of membrane lipids. It is involved in the pathogenesis of a number of diverse diseases. From the other side, the induction of ferroptosis can be used to kill tumor cells as a novel therapeutic approach. Because of the broad clinical relevance, a comprehensive understanding of the ferroptosis-controlling protein network is necessary. Noteworthy, several proteins from this network are flavoenzymes. This review is an attempt to present the ferroptosis-related flavoproteins in light of their involvement in anti-ferroptotic and pro-ferroptotic roles. When available, the data on the structural stability of mutants and cofactor-free apoenzymes are discussed. The stability of the flavoproteins could be an important component of the cellular death processes. Keywords: flavoproteins; riboflavin; ferroptosis; lipid peroxidation; protein quality control 1. Introduction Human flavoproteome encompasses slightly more than one hundred enzymes that par- ticipate in a number of key metabolic pathways. The chemical versatility of flavoproteins relies on the associated cofactors, flavin mononucleotide (FMN) and flavin adenine dinu- cleotide (FAD). In humans, flavin cofactors are biosynthesized from a precursor riboflavin that has to be supplied with food. To underline its nutritional essentiality, riboflavin is called vitamin B2. In compliance with manifold cellular demands, flavoproteins have been accommo- Citation: Vabulas, R.M. dated to operate at different subcellular locations [1]. -
Structural Enzymology of Sulfide Oxidation by Persulfide Dioxygenase and Rhodanese
Structural Enzymology of Sulfide Oxidation by Persulfide Dioxygenase and Rhodanese by Nicole A. Motl A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Biological Chemistry) in the University of Michigan 2017 Doctoral Committee Professor Ruma Banerjee, Chair Assistant Professor Uhn-Soo Cho Professor Nicolai Lehnert Professor Stephen W. Ragsdale Professor Janet L. Smith Nicole A. Motl [email protected] ORCID iD: 0000-0001-6009-2988 © Nicole A. Motl 2017 ACKNOWLEDGEMENTS I would like to take this opportunity to acknowledge the many people who have provided me with guidance and support during my doctoral studies. First I would like to express my appreciation and gratitude to my advisor Dr. Ruma Banerjee for the mentorship, guidance, support and encouragement she has provided. I would like to thank my committee members Dr. Uhn-Soo Cho, Dr. Nicolai Lehnert, Dr. Stephen Ragsdale and Dr. Janet Smith for their advice, assistance and support. I would like to thank Dr. Janet Smith and members of Dr. Smith’s lab, especially Meredith Skiba, for sharing their expertise in crystallography. I would like to thank Dr. Omer Kabil for his help, suggestions and discussions in various aspects of my study. I would also like to thank members of Dr. Banerjee’s lab for their suggestions and discussions. Additionally, I would like to thank my friends and family for their support. ii TABLE OF CONTENTS ACKNOWLEDGEMENTS ii LIST OF TABLES viii LIST OF FIGURES ix ABBREVIATIONS xi ABSTRACT xii CHAPTER I. Introduction: -
Diseases Catalogue
Diseases catalogue AA Disorders of amino acid metabolism OMIM Group of disorders affecting genes that codify proteins involved in the catabolism of amino acids or in the functional maintenance of the different coenzymes. AA Alkaptonuria: homogentisate dioxygenase deficiency 203500 AA Phenylketonuria: phenylalanine hydroxylase (PAH) 261600 AA Defects of tetrahydrobiopterine (BH 4) metabolism: AA 6-Piruvoyl-tetrahydropterin synthase deficiency (PTS) 261640 AA Dihydropteridine reductase deficiency (DHPR) 261630 AA Pterin-carbinolamine dehydratase 126090 AA GTP cyclohydrolase I deficiency (GCH1) (autosomal recessive) 233910 AA GTP cyclohydrolase I deficiency (GCH1) (autosomal dominant): Segawa syndrome 600225 AA Sepiapterin reductase deficiency (SPR) 182125 AA Defects of sulfur amino acid metabolism: AA N(5,10)-methylene-tetrahydrofolate reductase deficiency (MTHFR) 236250 AA Homocystinuria due to cystathionine beta-synthase deficiency (CBS) 236200 AA Methionine adenosyltransferase deficiency 250850 AA Methionine synthase deficiency (MTR, cblG) 250940 AA Methionine synthase reductase deficiency; (MTRR, CblE) 236270 AA Sulfite oxidase deficiency 272300 AA Molybdenum cofactor deficiency: combined deficiency of sulfite oxidase and xanthine oxidase 252150 AA S-adenosylhomocysteine hydrolase deficiency 180960 AA Cystathioninuria 219500 AA Hyperhomocysteinemia 603174 AA Defects of gamma-glutathione cycle: glutathione synthetase deficiency (5-oxo-prolinuria) 266130 AA Defects of histidine metabolism: Histidinemia 235800 AA Defects of lysine and -
The Requirement of Inorganic Fe-S Clusters for the Biosynthesis of the Organometallic Molybdenum Cofactor
inorganics Review The Requirement of Inorganic Fe-S Clusters for the Biosynthesis of the Organometallic Molybdenum Cofactor Ralf R. Mendel 1, Thomas W. Hercher 1, Arkadiusz Zupok 2, Muhammad A. Hasnat 2 and Silke Leimkühler 2,* 1 Institute of Plant Biology, Braunschweig University of Technology, Humboldtstr. 1, 38106 Braunschweig, Germany; [email protected] (R.R.M.); [email protected] (T.W.H.) 2 Department of Molecular Enzymology, Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Potsdam, Germany; [email protected] (A.Z.); [email protected] (M.A.H.) * Correspondence: [email protected]; Tel.: +49-331-977-5603; Fax: +49-331-977-5128 Received: 18 June 2020; Accepted: 14 July 2020; Published: 16 July 2020 Abstract: Iron-sulfur (Fe-S) clusters are essential protein cofactors. In enzymes, they are present either in the rhombic [2Fe-2S] or the cubic [4Fe-4S] form, where they are involved in catalysis and electron transfer and in the biosynthesis of metal-containing prosthetic groups like the molybdenum cofactor (Moco). Here, we give an overview of the assembly of Fe-S clusters in bacteria and humans and present their connection to the Moco biosynthesis pathway. In all organisms, Fe-S cluster assembly starts with the abstraction of sulfur from l-cysteine and its transfer to a scaffold protein. After formation, Fe-S clusters are transferred to carrier proteins that insert them into recipient apo-proteins. In eukaryotes like humans and plants, Fe-S cluster assembly takes place both in mitochondria and in the cytosol. -
Properties of Lipoamide Dehydrogenase and Thioredoxin Reductase from Escherichia Coti Altered by Site-Directed Mutagenesis“
Properties of Lipoamide Dehydrogenase and Thioredoxin Reductase from Escherichia coti Altered by Site-Directed Mutagenesis“ CHARLES H. WILLIAMS, JR.,~JNIGEL ALL IS ON,^,^ GEORGE c. RUSSELL! ANDREW J. PRONGAY,~ L. DAVID ARSCOTT,~SHOMPA DATTA,~ LENA SAHLMAN,~~AND JOHN R. GUEST^ Veterans Administration Medical Center and Department of Biological Chemistry University of Michigan Ann Arbor, Michigan 481 05 and dDepartment of Microbiology Shefield University Shefield SIO 2TN United Kingdom Lipoamide dehydrogenase and thioredoxin reductase are members of the pyridine nucleotidedisulfide oxidoreductase family of flavoenzymes, which is distinguished by an oxidation-reduction-active disulfide.’ Other members of the family, glutathione reductase and mercuric reductase, are homologous with lipoamide dehydrogenase in all domains.”5 Thioredoxin reductase is homologous with the others only in its two adenosine binding regions; the remainder of the protein, including its active-site disulfide region, appears to have evolved convergently.6 Catalysis takes place in two half-reactions, as shown in FIGUREI for lipoamide dehydrogenase.’” In the first, dithiol-disulfide interchange effects reduction of the oxidized enzyme (E) to the 2-electron reduced form of the enzyme (EH,); and in the second, the reoxidation of EH, to E, electrons pass very rapidly via the FAD to NAD’. The distinct roles of the two nascent thiols of EH, have been demonstrated.’”” The thiol nearer the amino terminus reacts almost exclusively with iodoacetamide, and it is this thiol that interchanges with the dithiol substrate; the sulfur nearer the carboxyl terminus interacts with the FAD. Similar results are seen with glutathione reductase” and mercuric reductase.” The assignment of roles to the two nascent thiols in ‘This work was supported by the Medical Research Service of the Veterans Administration, by Grant GM21444 from the National Institute of General Medical Sciences (to C.